{"id":"W3186485642","doi":"10.1182/bloodadvances.2021004770","title":"Prognostic significance of <i>FCGR2B</i> expression for the response of DLBCL patients to rituximab or obinutuzumab treatment","year":2021,"lang":"en","type":"article","venue":"Blood Advances","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Simon Fraser University; Canada's Michael Smith Genome Sciences Centre; University of British Columbia; Spinal Cord Injury BC","funders":"Imperial Experimental Cancer Medicine Centre; Blood Cancer UK; University of Southampton; F. Hoffmann-La Roche; Kay Kendall Leukaemia Fund; Michael Smith Health Research BC; National Cancer Institute; National Institutes of Health; Cancer Research UK; U.S. Department of Health and Human Services","keywords":"Obinutuzumab; CHOP; Rituximab; Vincristine; Hazard ratio; Internal medicine; Lymphoma; CD20; Medicine; Chemoimmunotherapy; Cyclophosphamide; Oncology; Cancer research; Chemistry; Immunology; Confidence interval; Chemotherapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004960069,0.0002090911,0.0003348971,0.0003138534,0.0002031988,0.00062777,0.0003301864,0.0005195584,0.001314965],"category_scores_gemma":[0.001501864,0.0001145299,0.0004083852,0.000376392,0.0003399897,0.0003043956,0.0002833342,0.0006753387,0.0002513579],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003622021,"about_ca_system_score_gemma":0.0002148091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001083585,"about_ca_topic_score_gemma":0.001358238,"domain_scores_codex":[0.9997142,0.00007441681,0.00002218469,0.0000716967,0.00004349628,0.00007404939],"domain_scores_gemma":[0.9990093,0.0002291741,0.0004368501,0.00005816874,0.00005869769,0.000207882],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001893654,0.00004721315,0.9906552,0.00001463537,0.0001033679,0.0001266743,0.00003412311,0.0002072645,0.002244947,0.00005092292,0.0002621418,0.004359722],"study_design_scores_gemma":[0.00007396194,0.0003166863,0.9970426,0.00001251769,0.0001291819,0.0004767407,0.00008723687,0.0007277206,0.0004984338,0.0001098441,0.0005158014,0.000009151762],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984609,0.0005834331,0.00005069018,0.00009171185,0.00000812716,0.000006504879,0.0001563461,0.00000448711,0.0006379012],"genre_scores_gemma":[0.9995624,0.00006402728,0.0000271906,0.00004037302,0.00001719367,0.000004290898,0.0001939893,0.000001720478,0.00008873181],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001314965,"threshold_uncertainty_score":0.004399002,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.032235789902938,"score_gpt":0.3410705343796894,"score_spread":0.3088347444767514,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}